share_log

HC Wainwright & Co. Maintains Buy on Addex Therapeutics, Lowers Price Target to $15

HC Wainwright & Co. Maintains Buy on Addex Therapeutics, Lowers Price Target to $15

HC Wainwright & Co.维持对Addex Therapeutics的买入,将目标价下调至15美元
Benzinga Real-time News ·  2022/05/31 06:28

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Addex Therapeutics (NASDAQ:ADXN) with a Buy and lowers the price target from $21 to $15.

HC Wainwright & Co. 分析师拉古拉姆·塞尔瓦拉朱维持Addex Therapeutics(纳斯达克股票代码:ADXN)的买入,并将目标股价从21美元下调至15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发